Scout Investments Inc. Invests $5.76 Million in Evolent Health, Inc. (NYSE:EVH)

Scout Investments Inc. purchased a new position in shares of Evolent Health, Inc. (NYSE:EVH) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 180,382 shares of the technology company’s stock, valued at approximately $5,760,000. Scout Investments Inc. owned approximately 0.16% of Evolent Health as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. ICA Group Wealth Management LLC bought a new stake in Evolent Health in the 4th quarter valued at $33,000. Headlands Technologies LLC bought a new stake in Evolent Health in the 1st quarter valued at $46,000. Signaturefd LLC lifted its position in Evolent Health by 1,470.7% in the 4th quarter. Signaturefd LLC now owns 1,445 shares of the technology company’s stock valued at $48,000 after acquiring an additional 1,353 shares in the last quarter. NBC Securities Inc. bought a new stake in Evolent Health in the 4th quarter valued at $69,000. Finally, Banque Cantonale Vaudoise bought a new stake in Evolent Health in the 1st quarter valued at $88,000.

Wall Street Analysts Forecast Growth

Several research firms recently commented on EVH. JMP Securities cut their price objective on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating on the stock in a research report on Friday, May 10th. Citigroup initiated coverage on shares of Evolent Health in a research note on Monday, April 22nd. They issued a “buy” rating and a $40.00 price target on the stock. Finally, Canaccord Genuity Group lowered their price target on shares of Evolent Health from $44.00 to $41.00 and set a “buy” rating on the stock in a research note on Friday, May 10th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $42.00.

Evolent Health Stock Performance

Shares of Evolent Health stock traded down $0.44 during trading on Friday, hitting $19.69. 1,109,271 shares of the stock were exchanged, compared to its average volume of 1,316,666. The stock has a market capitalization of $2.29 billion, a price-to-earnings ratio of -16.10 and a beta of 1.54. The company has a fifty day moving average price of $21.68 and a 200-day moving average price of $27.81. Evolent Health, Inc. has a 1-year low of $17.98 and a 1-year high of $35.00. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.57.

Evolent Health (NYSE:EVH) last released its quarterly earnings data on Thursday, May 9th. The technology company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.04. The company had revenue of $639.65 million for the quarter, compared to analyst estimates of $601.60 million. Evolent Health had a negative net margin of 5.07% and a positive return on equity of 6.90%. As a group, equities analysts predict that Evolent Health, Inc. will post 0.9 EPS for the current fiscal year.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.